pulmonary heart disease	is a	cardiac condition
pulmonary heart disease	is caused by	lung disease
pulmonary heart disease	leads to	right ventricular hypertrophy
pulmonary heart disease	results in	pulmonary hypertension
pulmonary heart disease	causes	cyanosis
pulmonary heart disease	is associated with	dyspnea
pulmonary heart disease	is diagnosed by	echocardiography
pulmonary heart disease	is confirmed with	cardiac MRI
pulmonary heart disease	is treated with	diuretics
pulmonary heart disease	is managed by	oxygen therapy
pulmonary heart disease	responds to	pulmonary vasodilators
pulmonary heart disease	worsens with	smoking
pulmonary heart disease	improves after	lung transplantation
pulmonary heart disease	increases risk of	arrhythmia
pulmonary heart disease	elevates	BNP levels
pulmonary heart disease	predicts	mortality
pulmonary heart disease	predicts	readmission
pulmonary heart disease	is a contraindication for	high‑dose beta‑blockers
pulmonary heart disease	is a risk factor for	venous thromboembolism
pulmonary heart disease	is linked to	sleep apnea
pulmonary heart disease	is associated with	chronic obstructive pulmonary disease
pulmonary heart disease	is related to	interstitial lung disease
pulmonary heart disease	is correlated with	pulmonary embolism
pulmonary heart disease	is a complication of	tuberculosis
pulmonary heart disease	is a sequela of	sarcoidosis
pulmonary heart disease	is a result of	pulmonary fibrosis
pulmonary heart disease	is a manifestation of	systemic sclerosis
pulmonary heart disease	is a feature of	cystic fibrosis
pulmonary heart disease	is a consequence of	emphysema
pulmonary heart disease	is a result of	bronchiectasis
pulmonary heart disease	is a complication of	pneumonia
pulmonary heart disease	is a sequela of	COVID‑19
pulmonary heart disease	is a risk factor for	sudden cardiac death
pulmonary heart disease	is a predictor of	exercise intolerance
pulmonary heart disease	is associated with	fatigue
pulmonary heart disease	is linked to	edema
pulmonary heart disease	is a cause of	ascites
pulmonary heart disease	is a reason for	jugular venous distension
pulmonary heart disease	is a factor in	right heart failure
pulmonary heart disease	is a driver of	pulmonary vascular remodeling
pulmonary heart disease	is a target for	endothelin receptor antagonists
pulmonary heart disease	is treated with	phosphodiesterase‑5 inhibitors
pulmonary heart disease	is managed by	prostacyclin analogs
pulmonary heart disease	is improved by	atrial septostomy
pulmonary heart disease	is reduced by	pulmonary rehabilitation
pulmonary heart disease	is monitored with	BNP testing
pulmonary heart disease	is evaluated by	right heart catheterization
pulmonary heart disease	is assessed with	6‑minute walk test
pulmonary heart disease	is correlated with	NT‑proBNP levels
pulmonary heart disease	is a predictor of	hospitalization
pulmonary heart disease	is a risk factor for	atrial fibrillation
pulmonary heart disease	is a cause of	tricuspid regurgitation
pulmonary heart disease	is a reason for	pacemaker implantation
pulmonary heart disease	is a trigger for	ventricular tachycardia
pulmonary heart disease	is a factor in	heart failure with preserved EF
pulmonary heart disease	is a determinant of	quality of life
pulmonary heart disease	is a predictor of	long‑term survival
pulmonary heart disease	is a marker for	disease progression
pulmonary heart disease	is associated with	anemia
pulmonary heart disease	is linked to	malnutrition
pulmonary heart disease	is a complication of	pulmonary hypertension
pulmonary heart disease	is a consequence of	left heart failure
pulmonary heart disease	is a result of	mitral valve disease
pulmonary heart disease	is a factor in	pulmonary embolism recurrence
pulmonary heart disease	is a predictor of	thromboembolic events
pulmonary heart disease	is a risk factor for	stroke
pulmonary heart disease	is a cause of	syncope
pulmonary heart disease	is a reason for	pacemaker implantation
pulmonary heart disease	is a driver of	systemic inflammation
pulmonary heart disease	is a target for	anti‑inflammatory therapy
pulmonary heart disease	is a consequence of	pulmonary fibrosis progression
pulmonary heart disease	is a predictor of	ICU admission
pulmonary heart disease	is a risk factor for	renal dysfunction
pulmonary heart disease	is a cause of	hepatic congestion
pulmonary heart disease	is a factor in	peripheral neuropathy
pulmonary heart disease	is a determinant of	medication adherence
pulmonary heart disease	is a predictor of	medication side effects
pulmonary heart disease	is a marker for	frailty
pulmonary heart disease	is a risk factor for	depression
pulmonary heart disease	is a cause of	social isolation
pulmonary heart disease	is a driver of	caregiver burden
pulmonary heart disease	is a target for	digital health monitoring
pulmonary heart disease	is a predictor of	telehealth utilization
pulmonary heart disease	is a factor in	health‑care costs
pulmonary heart disease	is a determinant of	insurance coverage
pulmonary heart disease	is a risk factor for	medication non‑compliance
pulmonary heart disease	is a cause of	polypharmacy
pulmonary heart disease	is a driver of	polypharmacy risk
pulmonary heart disease	is a predictor of	drug‑drug interactions
pulmonary heart disease	is a factor in	adverse drug reactions
pulmonary heart disease	is a target for	pharmacogenomic testing
pulmonary heart disease	is a consequence of	drug‑induced lung injury
pulmonary heart disease	is a risk factor for	medication‑induced hypertension
pulmonary heart disease	is a cause of	medication‑induced edema
pulmonary heart disease	is a predictor of	medication‑induced arrhythmia
pulmonary heart disease	is a determinant of	medication adherence
pulmonary heart disease	is a factor in	medication cost burden
pulmonary heart disease	is a driver of	medication optimization
pulmonary heart disease	is a target for	precision medicine
pulmonary heart disease	is a predictor of	personalized treatment outcomes
